Cost-Effectiveness Analysis of Medications in the Field of Sexual Medicine Offered by the Brazilian Universal Healthcare System at a Tertiary Hospital

Medicine is an indispensable component of healthcare systems. However, ensuring its availability, accessibility, rational use, cost-effectiveness, and sustainability poses challenges for most countries throughout the world. The present study involved a retrospective analysis of 7,929 medical appointments recorded in electronic medical records from 2016 to 2020 at a general specialty outpatient clinic of a tertiary-level teaching and research hospital in Brazil. A total of 1,377 prescriptions were issued for medications in the field of sexual medicine not available through the universal healthcare system, with a focus on erectile dysfunction (ED), offered to 1,015 patients. The results revealed sustainable ways of treating patients in specialized care with more complex drug therapy, even if such drugs are not on the National List of Essential Medications. This study demonstrated the importance of management with a focus on communication and synergistic interaction among healthcare providers. Medications for ED within the scope of the universal healthcare system, even if not available through pharmaceutical assistance programs, had a low rate of access through the courts (0.8%) compared to other specialties, but were offered in a cost-effective manner.

• Publication year

  2025

• Venue

  Cureus

• Publication date

  2025-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.7759/cureus.93772PMID 41185822PMCID 12579861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Does the pharmaceutical industry interfere in the sustainability of the public health system in Brazil? A reflection on the pressure for the incorporation of medicines].

  2022cited by this paper
• O acesso a medicamentos em sistemas universais de saúde – perspectivas e desafios

  2019cited by this paper
• Pharmacist's contribution to the promotion of access and rational use of essential medicines in SUS.

  2017cited by this paper
• Segurança do paciente no uso de medicamentos após a alta hospitalar: estudo exploratório1

  2014cited by this paper
• [Therapeutic itineraries of users of medication in a unit of the Family Heatlh Strategy].

  2012cited by this paper
• Itinerários terapêuticos de usuários de medicamentos de uma unidade de Estratégia de Saúde da Família

  2012cited by this paper
• Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONT

  2010cited by this paper
• ['Judicialization' of public health policy for distribution of medicines].

  2009cited by this paper
• Judicialização da política pública de assistência farmacêutica e eqüidade

  2009cited by this paper
• Medicamentos genéricos no Brasil: impactos das políticas públicas sobre a indústria nacional

  2008cited by this paper
• Erectile dysfunction in patients in a cardiac rehabilitation program.

  2008cited by this paper
• [Generic drugs in Brazil: impacts of public policies upon the national industry].

  2008cited by this paper
• Relação Nacional de Medicamentos Essenciais - Rename

  2007cited by this paper
• [Prescription and patient-care indicators in healthcare services].

  2004cited by this paper
• [Technology assessment in health care: methodological and operational questions].

  2004cited by this paper
• The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences

  1999cited by this paper
• Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.

  1994cited by this paper
• Harrison's Principles of Internal Medicine

  1988cited by this paper

• No citing papers are available for this paper.